Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Arance

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Clinical Breast Cancer|September 15, 2014
Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancerOlivier Trédan, Mario Campone, Jacek Jassem, et al.
International Journal of Molecular Sciences|July 13, 2024
Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in SpainNatalia Castrejon, Roberto Martin, Antonio Carrasco, et al.
Insights Into Imaging|November 19, 2025
Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse eventsGary Amseian, Francisco Aya, Camilo Pineda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2025
Clinical impact following the establishment of a specialized brain metastases tumor boardIzaskun Valduvieco, Gabriela Antelo, Alberto Di Somma, et al.
BMC Medicine|December 20, 2015
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapyAleix Prat, Cheng Fan, Aranzazu Fernández, et al.
Cancers|December 11, 2025
Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced MelanomaClara Martínez-Vila, Cristina Teixido, Roberto Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 8, 2022
SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021)María Martínez-García, Sonia Servitja Tormo, Noelia Vilariño Quintela, et al.
Cancer|March 29, 2014
A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanomaOmid Hamid, Robert Ilaria, Claus Garbe, et al.
International Journal of Cancer|July 26, 2021
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle EastPaolo Antonio Ascierto, Kristina Orlova, Giovanni Grignani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 6, 2020
Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanomaPaolo A Ascierto, Reinhard Dummer, Helen J Gogas, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Clinical Breast Cancer|September 15, 2014
Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancerOlivier Trédan, Mario Campone, Jacek Jassem, et al.
International Journal of Molecular Sciences|July 13, 2024
Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in SpainNatalia Castrejon, Roberto Martin, Antonio Carrasco, et al.
Insights Into Imaging|November 19, 2025
Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse eventsGary Amseian, Francisco Aya, Camilo Pineda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2025
Clinical impact following the establishment of a specialized brain metastases tumor boardIzaskun Valduvieco, Gabriela Antelo, Alberto Di Somma, et al.
BMC Medicine|December 20, 2015
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapyAleix Prat, Cheng Fan, Aranzazu Fernández, et al.
Cancers|December 11, 2025
Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced MelanomaClara Martínez-Vila, Cristina Teixido, Roberto Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 8, 2022
SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021)María Martínez-García, Sonia Servitja Tormo, Noelia Vilariño Quintela, et al.
Cancer|March 29, 2014
A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanomaOmid Hamid, Robert Ilaria, Claus Garbe, et al.
International Journal of Cancer|July 26, 2021
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle EastPaolo Antonio Ascierto, Kristina Orlova, Giovanni Grignani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 6, 2020
Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanomaPaolo A Ascierto, Reinhard Dummer, Helen J Gogas, et al.
Pageof 10